Announced
Completed
Financials
Sources
Tags
Acquisition
Private
Friendly
Single Bidder
India
pharmaceutical
Pharmaceuticals
Domestic
Majority
Private Equity
Completed
Synopsis
India Resurgence Fund, an India-focused distressed and special situations investment platform, completed the acquisition of the active pharmaceutical ingredients and contract research and manufacturing services business of Ind-Swift, a pharmaceutical manufacturing and marketing company, for $200m.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.